• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Brugada Syndrome Market

Brugada Syndrome Market, By Diagnosis (Electrocardiogram, Electrophysiology (Ep) Test, Genetic Testing), By Treatment (Implantable Cardioverter-Defibrillator), By End-User (Hospitals & Clinics, Diagnostic Centers)


Brugada syndrome is a hereditary condition that results in an abnormal electrical activity inside the heart, which in turn leads to the increasing danger of sudden cardiac death. In several cases, the abnormal heartbeats often occur when a patient is either sleeping, at rest or may be triggered by a fever. Disrupted sleep, breathing problems, fainting, seizures, nightmares, and sudden death are the signs and symptoms of Brugada syndrome. The signs and symptoms of Brugada syndrome are very much similar to some other heartbeats related problems. Brugada syndrome, known as unexplained unexpected nocturnal death syndrome (SUNDS), is an uncommon heart disease characterized by the irregular heartbeat. Brugada syndrome most frequently affects people during their thirties. However, symptoms can seem at any age. 40 is the average age of sudden death among people with Brugada syndrome.

Market scenario:
Due to change in lifestyle, rising adoption of the western culture among the adults and getting addicted to smoking. Additionally, exposure to harmful chemicals and increasing environmental pollution also causing number of heart diseases such as Cardiomyopathies (diseases that damage the heart muscles), Diseases of the Heart Valves, Coronary Artery Disease, Diabetes, Lung Disease, Heart Defects present at Birth, High Blood Pressure such as Emphysema and Past Heart Attacks and immense demand for diagnostic technologies such as: computed tomography (CT) and magnetic resonance imaging (MRI) , treatment methods and rising therapeutics demand are the factors that are driving the Brugada syndrome market. Additionally, the rising availability of diagnostic services for respiratory illness also fuels the growth of the market. Moreover, favorable compensation policies are likely to boost the market growth. However, low awareness and deficiency of health care services in the middle and low-income countries are estimated to suppress the market growth. Isoprenaline is the only drug used in the treatment of the disorder. Being a genetic disorder, the precise treatment of the disorder is not available, which is the major factor to hamper the growth of the market. As there are very few treatments and drugs available thus such genetic diseases require long-term treatment so it will create further future opportunities for companies due to very less competition.

According to NORD (National Organization for Rare Diseases)
Brugada syndrome is a transmitted disease and follows autosomal dominant inheritance. Presently, the prevalence of Brugada syndrome is estimated at 5 in 10,000 people.

Regional analysis:
The American Brugada syndrome market is bifurcated into two regions, namely, North America and South America. North America is providing ample market which is mainly driven by the increasing use of an electrocardiogram, Electrophysiology (EP) test for the diagnosis of the disease and immense population base diagnosed with heart-related diseases. Furthermore, the U.S. is the sizable market in North America owing to the presence of a large number of market participant manufacturing medications for Brugada syndrome and growing awareness about risk factors and cases of the disease. Canada is anticipated to be the fastest growing market which is driven by the overall increasing demand for diagnostic medical devices with advancement in the medical device sector. Due to technologically progressive devices for diagnosis and the increasing demand for treatment options of respiratory diseases South America is expected to be the fastest growing market. The European Brugada syndrome market displays a positive growth with an increasing emphasis on the diagnosis of heart diseases such as Brugada syndrome and others. Moreover, Germany and the UK are the leading presenters to the growth of the market. Additionally, the increased spending on health care by major countries in Europe also speeds up the growth of the market. Huge demand for diagnostic tests and increasing focus on early diagnosis and treatment of heart diseases in Asia Pacific is expected to be the fastest growing market. Furthermore, other factors contributing to the growth of the market is the steady rise with an increase in the number of healthcare facilities rendering treatment for chronic conditions.

Key players:
Some of the key players in Brugada syndrome market are:

  • GeneDx (U.S)
  • PGxHealth LLC (U.S)
  • Abbott (U.S)
  • GE Healthcare (U.K)
  • Medtronic (U.S.)
  • Pfizer, Inc (U.S)
  • Boston Scientific Corporation (U.S.)
  • GlaxoSmithKline (U.K)
  • Eli Lilly Company (U.S)
  • Taj Pharmaceuticals Ltd (India)

Brugada syndrome market is segmented as: 
By Diagnosis

  • Electrocardiogram
  • Electrophysiology (Ep) Test
  • Genetic Testing

By Treatment 

  • Implantable Cardioverter-Defibrillator

By End-User

  • Hospitals

  • Clinics

  • Diagnostic Centers

Based on region:

  • North America 

    • U.S

    • Canada 

    • Mexico 

  • Europe

    • Spain

    • U.K

    • Germany 

    • France 

    • Italy 

    • Rest of Europe 

  • Asia pacific

    • China 

    • India 

    • Japan 

    • South Korea

    • Australia 

    • Rest of Asia pacific  

  • LAMEA

    • Brazil

    • Argentina 

    • Saudi Arabia 

    • South Africa 

    • Rest of LAMEA


									

	

Related Reports

Global Calcium Supplement Market Insights, Forecast to 2025

In 2017, the global Calcium Supplement market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and pr ...read more

Global Cellular Allografts Market Size, Status and Forecast 2018-2025

In 2017, the global Cellular Allografts market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. This report focuses on the global C ...read more

Global Clinical Laboratory Testing Market Size, Status and Forecast 2018-2025

In 2017, the global Clinical Laboratory Testing market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. This report focuses on the ...read more

Global Cordyceps Sinensis Extract Market Size, Status and Forecast 2018-2025

In 2017, the global Cordyceps Sinensis Extract market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. This report focuses on the g ...read more

Global Digital Diagnostics Market Size, Status and Forecast 2018-2025

In 2017, the global Digital Diagnostics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. This report focuses on the global D ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.